AP214 ameliorates sepsis-induced acute kidney injury and mor(19)

NIH-PA Author Manuscript

NIH-PA Author Manuscript

NIH-PA Author ManuscriptFigure 9. AP214 improved survival of CLPAP214 treatment at the dose of 10 μg improved the survival rate both in lethal and sublethalCLP model. Open squares indicate lethal CLP group (n = 16), closed squares AP214 treatmentgroup in lethal CLP (n = 16), open circles sublethal CLP group (n = 20), and closed circlesAP214 treatment group in sublethal CLP (n =20). #, P < 0.05 vs. lethal CLP. ##, P < 0.05 vs.sublethal CLP.